NDC 71773-100

Xerava

Eravacycline

Xerava is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Tetraphase Pharmaceuticals, Inc.. The primary component is Eravacycline Dihydrochloride.

• Product ID: 71773-100_47ef366a-a414-4fbf-b5b2-22c12422b520
• NDC: 71773-100
• Product Type: Human Prescription Drug
• Proprietary Name: Xerava
• Generic Name: Eravacycline
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2018-09-10
• Marketing Category: NDA / NDA
• Application Number: NDA211109
• Labeler Name: Tetraphase Pharmaceuticals, Inc.
• Substance Name: ERAVACYCLINE DIHYDROCHLORIDE
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Tetracycline-class Antibacterial [EPC],Tetracyclines [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 71773-100-12

12 CARTON in 1 PACKAGE (71773-100-12) > 1 VIAL, GLASS in 1 CARTON (71773-100-05) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

• Marketing Start Date: 2020-09-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Xerava" or generic name "Eravacycline"

NDC	Brand Name	Generic Name
71773-050	Xerava	eravacycline
71773-100	Xerava	eravacycline